Sanofi says it hasn't increased its takeover bid for Genzyme

09/9/2010 | Boston Herald · Bloomberg Businessweek

Sanofi-Aventis said it is sticking with an $18.5 billion offer to take over Genzyme, dispelling a rumor that it increased its bid to more than $70 per share to woo the biotech firm's board members. Sanofi CEO Chris Viehbacher met with Genzyme's shareholders this week to pitch the $69-a-share offer, a spokesman said.

View Full Article in:

Boston Herald · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID